Expression of Interferon Regulatory Factor 8 (IRF8) and Its Association with Infections in Dialysis Patients

Author:

Friebus-Kardash Justa1ORCID,Kuang Fei2,Peitz Tobias1,Hamdan Thamer A.2,Eisenberger Ute1,Boss Kristina1,Kribben Andreas1,Lang Karl Sebastian2,Jahn Michael1ORCID

Affiliation:

1. Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany

2. Institute of Immunology, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany

Abstract

Patients on dialysis have dysfunctions of innate and adaptive immune system responses. The transcriptional factor IRF8 (interferon regulatory factor 8) is primarily expressed in plasmacytoid cells (pDCs) and myeloid dendritic cells (mDCs), playing a crucial role in the maturation of dendritic cells, monocytes, and macrophages, and contributing to protection against bacterial infections. The current study analyzed the expression patterns of IRF8 and assessed its association with the risk of infections in 79 dialysis patients compared to 44 healthy controls. Different subsets of leukocytes and the intracellular expression of IRF8 were measured using flow cytometry. Compared to the healthy controls, the dialysis patients showed significantly reduced numbers of pDCs and significantly increased numbers of natural killer cells and classical and intermediate monocytes. The dialysis patients exhibited decreased numbers of IRF8-positive dendritic cells (pDC p < 0.001, mDC1 p < 0.001, mDC2 p = 0.005) and increased numbers of IRF8-positive monocytes (p < 0.001). IRF8 expression in pDC, mDC, and classical monocytes was lower in the dialysis patients than in the controls. Dialysis patients who required hospitalization due to infections within one year of follow-up displayed significantly reduced IRF8 expression levels in pDCs compared to patients without such infections (p = 0.04). Our results suggest that reduced IRF8 expression in pDCs is a potential risk factor predisposing dialysis patients to serious infections.

Publisher

MDPI AG

Subject

General Medicine

Reference45 articles.

1. Cardiovascular disease in dialysis patients;Cozzolino;Nephrol. Dial. Transplant.,2018

2. Septicemia in dialysis patients: Incidence, risk factors, and prognosis;Powe;Kidney Int.,1999

3. Cohen, G. (2020). Immune Dysfunction in Uremia 2020. Toxins, 12.

4. Aspects of immune dysfunction in end-stage renal disease;Kato;Clin. J. Am. Soc. Nephrol.,2008

5. Changes in innate immunity in patients with chronic kidney disease;Borisov;Curr. Trends Immunol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3